Research & Development in Pharmaceutical Manufacturing
In line with our mission to develop meaningful products for the community, our R&D team is always searching for innovative solutions to common problems.
In development: A range of orally disintegrating strips (ODS) that offer an alternative to conventional oral formulations such as those in liquid or pill form. ODS has the ability to dissolve rapidly without water, providing an alternative to patients who are unable to swallow or suffering from nausea, such as those receiving chemotherapy. Due to the ease of administration, this results in better patient compliance and accurate dosing of the drugs. Clinical trials have been conducted and our manufacturing facility has recently been approved by the Pharmaceutical Inspection Co-operation Scheme (PIC/S).
Hart-S, a discreet erectile dysfunction treatment, will be the first launch from this range of products.
With our robust supply chain network and qualified pharmacists, we provide backend support and pharmaceutical supplies to our international clients’ ePharmacy businesses. Our distribution pharmacy is covered under a Good Distribution Practice (GDP) management system for Pharmaceutical Products and is certified to Good Distribution Practice for Medical Devices (GDPMDS).
We believe in making health accessible for the whole family – furry members included.
In 2023, we launched furlife, a pet health mobile app to improve preventative wellness in all animals. We distribute a range of pet supplements and preventatives, and have products in the R&D phase for manufacturing.